FORAY bioscience has filed a notice of an exempt offering of securities to raise $3,913,246.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, FORAY bioscience is raising up to $3,913,246.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Ashley Beckwith played a…